Theratechnologies Inc.

NASDAQ:THTX

3.15 (USD) • At close July 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996
Revenue 85.86681.76480.05769.82366.05363.21644.09933.30827.59322.4785.8777.11413.65814.45731.25816.5152.1273.1321.44514.0942.2313.0865.4772.860.8021.0190.7160.2810.371
Cost of Revenue 20.44819.63526.27923.2626.90226.07612.9737.9834.9563.0092.1433.4955.098.8570.460-0.514-0.002-0.204-2.367-0.418-0.92-3.0940.1520.0760.2040.195-0.1190.148
Gross Profit 65.41862.12953.77846.56339.15137.1431.12625.32522.63719.4683.7343.6198.5685.59930.79816.5152.6413.1341.64916.4612.6494.0068.5712.7080.7270.8150.5210.40.223
Gross Profit Ratio 0.7620.760.6720.6670.5930.5880.7060.760.820.8660.6350.5090.6270.3870.98511.2421.0011.1421.1681.1871.2981.5650.9470.9060.80.7271.4230.6
Reseach & Development Expenses 16.97330.3736.93928.27418.01910.8417.7769.2135.1773.6684.9046.9436.38310.64513.79521.01428.44531.8518.4811.7914.2918.68615.1018.874.2213.1922.8652.9522.672
General & Administrative Expenses 14.85215.61717.35614.61612.238.335.8284.5193.623.0333.9863.5935.49910.4817.84910.7956.771000000000000
Selling & Marketing Expenses 25.41926.76939.39128.90926.85926.48221.69320.2179.4168.2425.1980.2350.8581.9552.6192.4423.069000000000000
SG&A 40.27142.38656.74743.52539.08934.81227.52124.73613.03611.2759.1843.8296.35612.43710.46813.2379.849.6065.0715.5076.4486.2395.2443.7413.922.3772.3442.3892.004
Other Expenses 000000001.4941.425-2.7070000-1.372.794-0.8120.5491.0870.755-0.040.821-1.101-0.995-0.747-0.911-0.632-0.519
Operating Expenses 57.24472.75693.68671.79957.10845.65334.54233.94919.70616.36811.38110.77212.7423.08224.26232.88141.07940.64524.118.38421.49224.88521.16611.517.1474.8224.2974.7084.156
Operating Income 8.174-10.627-39.908-25.236-17.957-8.513-3.561-8.6242.9313.1-11.235-4.223-4.172-18.1756.535-15.833-38.952-37.512-22.655-4.29-19.261-20.212-15.689-8.803-6.42-4.007-3.776-4.427-4.007
Operating Income Ratio 0.095-0.13-0.498-0.361-0.272-0.135-0.081-0.2590.1060.138-1.912-0.594-0.305-1.2570.209-0.959-18.317-11.975-15.683-0.304-8.633-6.549-2.864-3.078-8-3.933-5.273-15.75-10.8
Total Other Income Expenses Net -14.475-12.909-6.886-6.426-4.694-3.983-2.408-5.713-2.15-1.52.0590.4280.9170.9362.3351.504-0.465-0.0570-7.99-1.50806.718.803000.4560.4220.371
Income Before Tax -6.301-23.536-46.794-31.662-22.651-12.496-5.969-14.3370.7811.6-9.176-3.795-14.028-17.248.871-14.329-39.418-37.5690-12.28-20.769-27.672-8.97816.5612.3440-3.32-4.006-3.636
Income Before Tax Ratio -0.073-0.288-0.585-0.453-0.343-0.198-0.135-0.430.0280.071-1.561-0.533-1.027-1.1930.284-0.868-18.536-11.9940-0.871-9.309-8.966-1.6395.7912.920-4.636-14.25-9.8
Income Tax Expense 2.0050.4210.4430.0630.0160-1.26900.4760.4260.0270.0240.005-0.070.1120-0.465-0.0570-7.99-1.508-2.4250.183-25.78-10.194-0.67900-0.223
Net Income -8.306-23.957-47.237-31.725-22.667-12.496-4.7-14.3370.3051.175-9.203-3.819-14.033-17.178.759-14.237-39.418-37.569-22.655-12.28-19.216-25.247-9.16116.9783.774-3.328-3.32-4.006-3.488
Net Income Ratio -0.097-0.293-0.59-0.454-0.343-0.198-0.107-0.430.0110.052-1.566-0.537-1.027-1.1880.28-0.862-18.536-11.994-15.683-0.871-8.613-8.18-1.6735.9374.703-3.267-4.636-14.25-9.4
EPS -0.17-0.33-0.5-0.34-0.29-0.23-0.06-0.20.0070.022-0.15-0.063-0.23-0.280.15-0.24-0.69-0.71-0.53-0.34-0.56-0.82-0.30.620.16-0.16-0.18-0.24-0.24
EPS Diluted -0.17-0.33-0.5-0.34-0.29-0.23-0.06-0.20.0070.015-0.15-0.063-0.23-0.280.15-0.24-0.69-0.71-0.53-0.34-0.54-0.82-0.30.60.16-0.16-0.18-0.24-0.24
EBITDA 6.879-8.906-27.826-17.25-8.769-0.0110.788-11.7243.7864.904-7.128-3.681-3.604-17.1619.328-13.726-36.413-36.401-21.74-2.972-18.165-14.457-14.253-8.175-6.119-3.803-3.711-4.287-3.933
EBITDA Ratio 0.08-0.109-0.348-0.247-0.133-00.018-0.3520.1370.218-1.213-0.517-0.264-1.1870.298-0.831-17.123-11.621-15.049-0.211-8.142-4.684-2.602-2.859-7.626-3.733-5.182-15.25-10.6